Zhu et al. [10] revealed another molecular pathway of the hsa_circ_0004018/miR-626/DKK3 regulatory axis that inhibits the Wnt/β-catenin signaling pathway, which may be a potential therapeutic target in HCC. Here, DKK3 is linked to hepatocellular carcinoma.